Role of multiparametric magnetic resonance imaging in the diagnosis and staging of urinary bladder cancer
- PMID: 36204360
- PMCID: PMC9527936
- DOI: 10.1097/CU9.0000000000000128
Role of multiparametric magnetic resonance imaging in the diagnosis and staging of urinary bladder cancer
Abstract
Objectives: To assess the role of multiparametric magnetic resonance imaging (mp-MRI) in the diagnosis and staging of urinary bladder cancer (BC).
Materials and methods: Fifty patients diagnosed with bladder masses underwent mp-MRI study. The results of 3 image sets were analyzed and compared with the histopathological results as a reference standard: T2-weighted image (T2WI) plus dynamic contrast-enhanced (DCE), T2WI plus diffusion-weighted images (DWI), and mp-MRI, including T2WI plus DWI and DCE. The diagnostic accuracy of mp-MRI was evaluated using receiver operating characteristic curve analysis.
Results: The accuracy of T2WI plus DCE for detecting muscle invasion of BC was 79.5% with a fair agreement with histopathological examination (κ = 0.59); this percentage increased up to 88.6% using T2WI plus DWI, with good agreement with histopathological examination (κ = 0.74), whereas mp-MRI had the highest overall accuracy (95.4%) and excellent agreement with histopathological data (κ = 0.83). Multiparametric MRI can differentiate between low- and high-grade bladder tumors with a high sensitivity and specificity of 93.3% and 98.3%, respectively.
Conclusions: Multiparametric MRI is an acceptable method for the preoperative detection and accurate staging of BC, with reasonable accuracy in differentiating between low- and high-grade BC.
Keywords: Apparent diffusion coefficient; Bladder cancer; Diffusion-weighted imaging; Multiparametric magnetic resonance imaging; Transurethral resection of bladder tumor.
Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
No conflict of interest has been declared by the authors.
Figures





References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424. - PubMed
-
- Babjuk M Böhle A Burger M, et al. . EAU guidelines on non‐muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol 2017;71(3):447–461. - PubMed
-
- Kulkarni GS Hakenberg OW Gschwend JE, et al. . An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 2010;57(1):60–70. - PubMed
-
- El-Barky E, Sebaey A, Eltabey M, Aboutaleb A, Hussein S, Kehinde EO. The importance of second-look transurethral resection for superficial bladder cancer. J Clin Urol 2015;8(5):299–305.
LinkOut - more resources
Full Text Sources